Drug Profile
MMR vaccine - Hard to Treat Diseases
Alternative Names: Measles mumps and rubella virus vaccine - Hard to Treat DiseasesLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Hard To Treat Diseases
- Class Measles vaccines; Rubella vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Measles; Mumps; Rubella
Most Recent Events
- 09 Sep 2015 MMR vaccine is still in prereregistration for measles, mumps and rubella in China